- Market Realist•2 days ago
The consensus 12-month target price for Alexion is $180.8, which translates to a ~44.1% return over its closing price of $125.46 on July 18, 2016.
- Motley Fool•4 days ago
EPS estimates for Gilead Sciences, Alexion Pharmaceuticals, and BioMarin Pharmaceutical could be cut, but that's not a reason for investors to worry.
BioMarin Pharmaceutical Inc.NasdaqGS
After hours: 93.580.00 (0.00%) as of 5:01 PM EDT
|Bid||91.50 x 100|
|Ask||131.80 x 100|
|52wk Range||62.12 - 148.30|
|Day's Range||93.36 - 95.49|
|Avg Vol (3m)||1,578,596|
As of 4:00 PM EDT. Market closed.